Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318110 · ClinicalTrials.gov registry record · Phase 2
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
A Phase 2 study, sponsored by Center for International Blood and Marrow Transplant Research.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00318110: Clinical Trial Phase 2 study, sponsored by Center for International Blood and Marrow Transplant Research.
NCT00318110 is a Phase 2 study that was terminated before completion, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00318110, a Phase 2 study, was terminated before completion, sponsored by Center for International Blood and Marrow Transplant Research.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects (good and bad) a stem cell transplant from an unrelated donor will have for patients with kidney cancer that has spread to other parts of the body (metastasized).
Interventions
- PROCEDURE NST using MUD for metastatic renal cell carcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Why NCT00318110 stopped before completion
NCT00318110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which NST using MUD for metastatic renal cell carcinoma is the first listed.
NCT00318110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00318110 about?
NCT00318110 is a clinical study titled "Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma". The purpose of this study is to find out what effects (good and bad) a stem cell transplant from an unrelated donor will have for patients with kidney cancer that has spread to other parts of the body (metastasized).
What is the current status of trial NCT00318110?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2006-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00318110?
The interventions under investigation include: NST using MUD for metastatic renal cell carcinoma (PROCEDURE).
Who is sponsoring clinical trial NCT00318110?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00318110's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia